NOW vs WDAY: side-by-side analysis
Cross-read of NOW (ServiceNow Inc.) versus WDAY (Workday Inc.): NOW screens modestly overvalued at $91.2 versus a fair-value midpoint of $78.8, while WDAY appears in our peer table. Our current rating for NOW is Reduce.
Where NOW and WDAY sit on fair value
NOW's composite fair-value range is $51.1–$109 (midpoint $78.8), versus a current price of $91.2. WDAY is one of NOW's closest sector neighbours and shows up directly in the peer table inside our full report. The cross-read is editorial: same archetype expectations, same discount-rate philosophy, different operating model.
Both names are evaluated under the same six-factor decision overlay (customer value, unit economics, TAM, moat durability, risk profile, valuation) so comparing them is apples-to-apples rather than headline-multiple-to-headline-multiple. The rating differential between NOW and WDAY is driven by where each lands across those six axes, not by who looks "cheaper" on a single screen.
Where they actually differ
NOW is classified as a mature compounder stock; the archetype dictates our deceleration curve, terminal multiple, and probability weights. WDAY, depending on its own archetype, will have its own calibration — and that is precisely why simple peer multiples can mislead. A 18.2× forward P/E with a PEG of 1.07 is not the same on NOW as it is on WDAY unless they share the same growth profile, capital intensity, and moat half-life.
NOW's moat assessment is 9/10, and the full moat section in the report covers the source (network effects, switching costs, intangibles, scale, etc.) plus the timeline of any threats. The cross-read against WDAY should focus on which company's economic profit (ROIC minus WACC) is wider AND more durable — that is the variable that dominates long-run total return between two same-sector names.
Which one wins on each dimension
Valuation: NOW screens modestly overvalued versus our fair-value midpoint. The full report's peer table compares NOW and WDAY directly on P/E, PEG, EV/EBITDA, ROE, and operating margin. Risk: the bear case for NOW is bound by the kill-scenarios list in Section 2; the equivalent for WDAY would need its own report. We do not co-rate two companies on a single page.
Capital allocation and growth runway typically separate same-sector pairs more than the headline numbers suggest. The full report's capital-allocation paragraph and TAM analysis are the lenses we recommend before deciding whether NOW or WDAY is the better expression of the same theme.
Bottom line — NOW or WDAY?
Our rating for NOW is Reduce with a 86/100 confidence score; the rating already accounts for the relative-value information embedded in the peer table that includes WDAY. The cross-read is most useful when the two companies are real substitutes in a portfolio (same factor exposure, same end markets, same archetype) — otherwise the comparison is theatre.
For the full evidence on NOW, including the explicit peer multiples versus WDAY and the rest of the comp set, see the canonical report at /stocks/now/analysis. For WDAY's standalone report, see /stocks/wday/analysis.
Frequently asked questions
NOW vs WDAY: which is cheaper today?
NOW screens modestly overvalued at $91.2 versus a fair-value midpoint of $78.8 (range $51.1–$109). The peer table inside the full report compares NOW and WDAY directly on P/E, PEG, EV/EBITDA, ROE, and operating margin.
Is NOW a better buy than WDAY?
Our current rating for NOW is Reduce; we do not co-rate WDAY on this page — see WDAY's own report. The cross-read is most useful for relative positioning, not for choosing one over the other in isolation.
What archetype is NOW?
ServiceNow Inc. is classified as a mature compounder stock, which determines our deceleration curve, terminal multiple, and probability weights. WDAY's own archetype is in its own report.
What is NOW's moat score versus WDAY?
NOW's moat score is 9/10. The full moat section covers source, durability, and threat timeline; WDAY's moat assessment is in its own standalone report.
Research for educational purposes. Not personalised investment advice. See the full NOW report for the canonical evidence.